Published in Pharmacol Biochem Behav on July 01, 1989
The neurobiology of social play and its rewarding value in rats. Neurosci Biobehav Rev (2016) 0.80
Modality-specific retrograde amnesia of fear. Science (1992) 9.36
Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci (1981) 4.20
Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus (2001) 3.79
The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev (1999) 3.66
Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res (1997) 3.27
Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. J Neurosci (1999) 2.92
Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A (1999) 2.88
Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav Neurosci (1993) 2.78
Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci (1998) 2.09
Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J Neurosci (1995) 2.09
Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci U S A (1999) 1.79
Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. Behav Neurosci (1996) 1.72
N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. Behav Neurosci (1996) 1.67
Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats. Neurobiol Learn Mem (1997) 1.66
The amygdala and fear conditioning: has the nut been cracked? Neuron (1996) 1.63
Naloxone and shock-elicited freezing in the rat. J Comp Physiol Psychol (1979) 1.61
Sex differences in hippocampal long-term potentiation (LTP) and Pavlovian fear conditioning in rats: positive correlation between LTP and contextual learning. Brain Res (1994) 1.55
Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci (1998) 1.44
Immediate-early gene expression in the amygdala following footshock stress and contextual fear conditioning. Brain Res (1998) 1.40
NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. Behav Neurosci (1994) 1.38
Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology (1999) 1.37
Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci U S A (1997) 1.33
Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. Behav Neurosci (1992) 1.31
Sex differences, context preexposure, and the immediate shock deficit in Pavlovian context conditioning with mice. Behav Neurosci (2001) 1.27
The hippocampus, consolidation and on-line memory. Curr Opin Neurobiol (1998) 1.20
N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav Neurosci (1991) 1.16
Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann N Y Acad Sci (1986) 1.14
Associative regulation of Pavlovian fear conditioning: unconditional stimulus intensity, incentive shifts, and latent inhibition. J Exp Psychol Anim Behav Process (1992) 1.14
Cholinergic modulation of pavlovian fear conditioning: effects of intrahippocampal scopolamine infusion. Hippocampus (2001) 1.11
Odors released by stressed rats produce opioid analgesia in unstressed rats. Behav Neurosci (1985) 1.11
Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats. Neurobiol Learn Mem (1995) 1.08
Amygdala-dependent and amygdala-independent pathways for contextual fear conditioning. Neuroscience (2007) 1.08
Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci Biobehav Rev (1993) 1.06
Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography. Neurosci Biobehav Rev (1998) 1.05
The startled seahorse: is the hippocampus necessary for contextual fear conditioning? Trends Cogn Sci (1998) 1.03
Inhaled anesthetic responses of recombinant receptors and knockin mice harboring α2(S270H/L277A) GABA(A) receptor subunits that are resistant to isoflurane. J Pharmacol Exp Ther (2010) 1.01
Trace and contextual fear conditioning is enhanced in mice lacking the alpha4 subunit of the GABA(A) receptor. Neurobiol Learn Mem (2009) 0.99
The concentration of isoflurane required to suppress learning depends on the type of learning. Anesthesiology (2001) 0.98
Parallel augmentation of hippocampal long-term potentiation, theta rhythm, and contextual fear conditioning in water-deprived rats. Behav Neurosci (1994) 0.94
Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning. Neurobiol Learn Mem (1995) 0.92
Exposure to a cat produces opioid analgesia in rats. Behav Neurosci (1985) 0.90
Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test. Neuroscience (2010) 0.88
Effects of cerebellar vermal lesions on species-specific fear responses, neophobia, and taste-aversion learning in rats. Physiol Behav (1987) 0.87
Endorphins and behavior. Annu Rev Psychol (1982) 0.87
Shock-induced analgesia on the formalin test: effects of shock severity, naloxone, hypophysectomy, and associative variables. Behav Neurosci (1984) 0.86
Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia. Physiol Behav (1987) 0.86
The development of morphine-induced antinociception in neonatal rats: a comparison of forepaw, hindpaw, and tail retraction from a thermal stimulus. Pharmacol Biochem Behav (1993) 0.85
Morphine and acceptability of putative reinforcers. Pharmacol Biochem Behav (1983) 0.84
Tonic nociception in neonatal rats. Pharmacol Biochem Behav (1990) 0.84
Differential effects of selective opioid peptide antagonists on the acquisition of pavlovian fear conditioning. Peptides (1992) 0.84
Testicular hormones do not regulate sexually dimorphic Pavlovian fear conditioning or perforant-path long-term potentiation in adult male rats. Behav Brain Res (1998) 0.83
Species-specific danger signals, endogenous opioid analgesia, and defensive behavior. J Exp Psychol Anim Behav Process (1986) 0.83
Opiate modulation of the active and inactive components of the postshock reaction: parallels between naloxone pretreatment and shock intensity. Behav Neurosci (1984) 0.83
Body temperature as a conditional response measure for pavlovian fear conditioning. Learn Mem (2000) 0.83
Peripheral versus intracerebroventricular administration of quaternary naltrexone and the enhancement of Pavlovian conditioning. Brain Res (1988) 0.82
Anxiety: at the intersection of genes and experience. Nat Neurosci (1999) 0.80
Pavlovian conditioning alters cortical microtubule-associated protein-2. Neuroreport (1994) 0.79
Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution. Pharmacol Biochem Behav (1990) 0.79
Opioid and nonopioid conditional analgesia: the role of spinal opioid, noradrenergic, and serotonergic systems. Behav Neurosci (1991) 0.79
Differential effects of neurokinin-1 receptor activation in subregions of the periaqueductal gray matter on conditional and unconditional fear behaviors in rats. Behav Neurosci (1998) 0.78
Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266. Behav Neurosci (1989) 0.78
Strain differences in reversal of conditional analgesia by opioid antagonists. Behav Neurosci (1987) 0.78
Water deprivation enhances fear conditioning to contextual, but not discrete, conditional stimuli in rats. Behav Neurosci (1994) 0.78
Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test. Eur J Pharmacol (1988) 0.78
Cats produce analgesia in rats on the tail-flick test: naltrexone sensitivity is determined by the nociceptive test stimulus. Brain Res (1990) 0.77
Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide. J Pharmacol Exp Ther (1989) 0.77
Delta opioid antagonist, 16-Me cyprenorphine, selectively attenuates conditional fear- and DPDPE-induced analgesia on the formalin test. Pharmacol Biochem Behav (1989) 0.76
Direct microinjection of cathinone into the rat brain produces discriminative stimuli. Pharmacol Biochem Behav (1992) 0.76
Explicitly unpaired delivery of morphine and the test situation: extinction and retardation of tolerance to the suppressing effects of morphine on locomotor activity. Behav Neural Biol (1982) 0.76
A temporal analysis of naloxone's suppressant effect on drinking. Pharmacol Biochem Behav (1982) 0.76
Appetitive motivational states differ in their ability to augment aversive fear conditioning in rats (Rattus norvegicus). J Exp Psychol Anim Behav Process (1998) 0.75
Reduction of learned helplessness by central administration of quaternary naltrexone. Physiol Behav (1992) 0.75
[D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors. Peptides (1989) 0.75
Opioid-induced linear running in obese (ob/ob) and lean mice. Pharmacol Biochem Behav (1987) 0.75
Quaternary naltrexone reveals the central mediation of conditional opioid analgesia. Pharmacol Biochem Behav (1987) 0.75
Ethylketocyclazocine and bremazocine analgesia in neonatal rats. Pharmacol Biochem Behav (1988) 0.75
Central and peripheral injection of quaternary antagonist, SR58002C, reduces drinking. Physiol Behav (1987) 0.75
Pro-Leu-Gly-NH2 serves as a conditioned stimulus in the acquisition of conditioned tolerance. Behav Neurosci (1989) 0.75